Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...

The FDA on Tuesday signed off on SpringWorks Therapeutics’ mirdametinib—now to carry the brand name Gomekli—for the treatment ...

What will it take for a clinical-stage biotech to break into the cardio space? One CEO thinks he has the answer.

The partnership between the US military body and the non-profit Global Coalition for Adaptive Research will examine three ...

Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...

Merck KGaA fought for years to get the drug approved after rejection by the ... to be approved for this indication after Novartis’ brand new Mayzent (siponimod) which got a green light from ...

The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...

As advertisers pay more for an ever-scarcer supply of ratings points, pharma’s ironclad devotion to TV could finally be in ...

Ertugliflozin has also been approved in combination with metformin under the brand name Segluromet ... the other leading market for the drugs. Merck and Pfizer began a collaboration in 2013 ...

AstraZeneca reports mixed results in the fourth quarter. It gains in pre-market after assuring investors that the business ...

Astex Pharmaceuticals has been celebrating a very successful first 25 years following a visit from Science minister Patrick ...

Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...